NCT04927806

Brief Summary

The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 9, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 16, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

June 9, 2021

Last Update Submit

February 27, 2023

Conditions

Keywords

Bacterial contaminationnosocomail infectionbacterial detection rate

Outcome Measures

Primary Outcomes (1)

  • bacterial contamination

    comparison of the two ventilator systems

    one month

Secondary Outcomes (1)

  • bacterial detection rate

    one month

Study Arms (2)

SilverKnight group

EXPERIMENTAL

Silver Knight is an anti-microbial additive that uses silver ions to disrupt the normal enzymatic activities of bacteria

Device: Silver Knight

Control group

NO INTERVENTION

The control group uses standard ventilator circuits.

Interventions

Silver Knight breathing systems are all validated for up to seven days use, and remain active, in unopened packaging, for up to five years. Silver Knight is proven to help reduce the incidence of MRSA infection and other organisms including: * Staphyloccus epidermis * Pseudomonas aeruginosa * Klebsiella pneumoniae * Acinetobacter calcoaceticus * Escherichia coli

SilverKnight group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • mechanical ventilators in Medisive CareUnit (MICU)

You may not qualify if:

  • Using ventilators for less than seven days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fu Jen Catholic University Hospital, Fu Jen Catholic University

New Taipei City, 24352, Taiwan

Location

Related Publications (2)

  • Zilahi G, Artigas A, Martin-Loeches I. What's new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016 Dec;6(1):96. doi: 10.1186/s13613-016-0199-4. Epub 2016 Oct 6.

    PMID: 27714706BACKGROUND
  • Chao KY, Liu WL, Chen CY, Su CH, Yang SH, Huang YT. Bacterial Colonization of Silver-Additive Ventilator Circuit in Patients Receiving Mechanical Ventilation: A Randomized Controlled Trial. Clin Respir J. 2025 Mar;19(3):e70058. doi: 10.1111/crj.70058.

Study Officials

  • Wen-Lun Liu, MD

    Department of Emergency and Critical Care Medicine, Fu Jen Catholic University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: In this study, we conduct a cluster-randomized crossover, multicenter trial.There are two groups: 1. Control group: standard ventilator circuit in odd number month. 2. Experimental group: Silver Knight in even number month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Group leader of Respiratory Therapists

Study Record Dates

First Submitted

June 9, 2021

First Posted

June 16, 2021

Study Start

November 1, 2021

Primary Completion

June 1, 2022

Study Completion

June 30, 2022

Last Updated

March 1, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations